- Home
- ZYXI vs DSM Comparison
ZYXI vs DSM Comparison
Compare ZYXI & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZYXI
- DSM
- Stock Information
- Founded
- ZYXI 1996
- DSM 1989
- Country
- ZYXI United States
- DSM United States
- Employees
- ZYXI N/A
- DSM N/A
- Industry
- ZYXI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- DSM Investment Managers
- Sector
- ZYXI Health Care
- DSM Finance
- Exchange
- ZYXI Nasdaq
- DSM Nasdaq
- Market Cap
- ZYXI 265.0M
- DSM 301.0M
- IPO Year
- ZYXI N/A
- DSM N/A
- Fundamental
- Price
- ZYXI $8.58
- DSM $5.80
- Analyst Decision
- ZYXI Strong Buy
- DSM
- Analyst Count
- ZYXI 2
- DSM 0
- Target Price
- ZYXI $14.00
- DSM N/A
- AVG Volume (30 Days)
- ZYXI 70.7K
- DSM 161.7K
- Earning Date
- ZYXI 10-24-2024
- DSM 01-01-0001
- Dividend Yield
- ZYXI N/A
- DSM 3.97%
- EPS Growth
- ZYXI N/A
- DSM N/A
- EPS
- ZYXI 0.15
- DSM N/A
- Revenue
- ZYXI $193,665,000.00
- DSM N/A
- Revenue This Year
- ZYXI $10.70
- DSM N/A
- Revenue Next Year
- ZYXI $19.78
- DSM N/A
- P/E Ratio
- ZYXI $55.86
- DSM N/A
- Revenue Growth
- ZYXI 4.21
- DSM N/A
- 52 Week Low
- ZYXI $7.15
- DSM $4.69
- 52 Week High
- ZYXI $13.77
- DSM $6.05
- Technical
- Relative Strength Index (RSI)
- ZYXI 55.14
- DSM 27.44
- Support Level
- ZYXI $8.13
- DSM $5.76
- Resistance Level
- ZYXI $8.62
- DSM $6.18
- Average True Range (ATR)
- ZYXI 0.29
- DSM 0.06
- MACD
- ZYXI 0.04
- DSM -0.03
- Stochastic Oscillator
- ZYXI 82.93
- DSM 8.33
About ZYXI Zynex Inc.
Zynex Inc is engaged in the manufacturing and marketing of medical devices. It operates through one primary business segment, Electrotherapy and Pain Management Products. The business activities of the company are carried out through its subsidiaries. The company designs, manufactures, and markets medical devices that treat chronic and acute pain, as well as activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company markets Zynex-manufactured products which include NexWave, NeuroMove, InWave E-Wave, and others.
About DSM BNY Mellon Strategic Municipal Bond Fund Inc.
BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.